generated: '2026-07-24'
method: searched
source: >-
  Observed 307 redirect from https://docs.rhapsody.health/ to the AWS Cognito
  hosted UI (lyniate-docs.auth.us-east-1.amazoncognito.com/oauth2/authorize);
  https://rhapsody.health/solutions/rhapsody-axon/
note: >-
  Rhapsody's product REST/administration and FHIR API reference is gated behind
  docs.rhapsody.health, so the product APIs' own security schemes are not
  publicly observable and are NOT asserted here (no public OpenAPI to derive
  from). What IS observable is the authentication fronting the developer surface:
  the documentation portal and the Axon agent both sit behind enterprise SSO.
  This profile records that observed surface honestly; it is not a claim about
  the product API token model.
summary:
  types: [oauth2, openIdConnect]
  oauth2_flows: [authorizationCode]
  gated: true
schemes:
- name: docs-portal-sso
  surface: Developer documentation portal (docs.rhapsody.health)
  type: oauth2
  flow: authorizationCode
  pkce: S256
  provider: AWS Cognito (user pool "lyniate-docs", us-east-1)
  authorizationUrl: https://lyniate-docs.auth.us-east-1.amazoncognito.com/oauth2/authorize
  scopes: [openid, email, profile]
  evidence: 307 redirect from docs host to Cognito /oauth2/authorize with response_type=code
- name: axon-agent-sso
  surface: Rhapsody Axon AI agent (chat.axon.rhapsody.health)
  type: openIdConnect
  provider: OneLogin
  access: Existing Rhapsody / Corepoint customers only
  evidence: Axon solution page states access via OneLogin for existing customers
product_api_auth:
  status: gated
  detail: >-
    Rhapsody and Corepoint expose REST administration APIs (Corepoint 7.5.3
    Administration REST API) and FHIR APIs whose authentication is documented in
    the gated developer portal; not verifiable from a public specification.